To be or not to be in normal sinus rhythm: What do we really know?

被引：6

作者：

Bahnson, TD ^{[1
]}

Grant, AO ^{[1
]}

机构：

[1] Duke Univ, Ctr Med, Durham, NC 27710 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2004年 / 141卷 / 09期

关键词：

D O I：

10.7326/0003-4819-141-9-200411020-00016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Two papers in this issue raise questions about managing atrial fibrillation: Does rhythm control have any role in treating patients similar to the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study sample? Is it useful in any other patients? Does being in normal sinus rhythm provide significant benefits? If so, why didn't the rhythm control group in AFFIRM have better outcomes? Finally, what is a reasonable approach to treating patients with atrial fibrillation?

引用

页码：727 / 729

页数：3

共 16 条

[1] Impact of atrial fibrillation on the risk of death [J].

Benjamin, EJ ;

Wolf, PA ;

D'Agostino, RB ;

Silbershatz, H ;

Kannel, WB ;

Levy, D .

CIRCULATION, 1998, 98 (10) :946-952

[2] Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study [J].

Corley, SD ;

Epstein, AE ;

DiMarco, JP ;

Domanski, MJ ;

Geller, N ;

Greene, HL ;

Josephson, RA ;

Kellen, JC ;

Klein, RC ;

Krahn, AD ;

Mickel, M ;

Mitchell, LB ;

Nelson, JD ;

Rosenberg, Y ;

Schron, E ;

Shemanski, L ;

Waldo, AL ;

Wyse, DG .

CIRCULATION, 2004, 109 (12) :1509-1513

[3] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].

ECHT, DS ;

LIEBSON, PR ;

MITCHELL, LB ;

PETERS, RW ;

OBIASMANNO, D ;

BARKER, AH ;

ARENSBERG, D ;

BAKER, A ;

FRIEDMAN, L ;

GREENE, HL ;

HUTHER, ML ;

RICHARDSON, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788

[4] Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study [J].

Epstein, AE ;

Slabaugh, J ;

Barnard, D ;

Hammitt, L ;

Kaplan, AJ ;

Allen, B ;

Lui, C ;

Aguirre, L ;

Koshkarian, GM ;

Spiegler, K ;

Goldman, S ;

Ohm, J ;

Greer, G ;

Daly, J ;

Bissett, JK ;

Cotter, B ;

Dennish, GW ;

Jones, C ;

Pai, S ;

Bishop, V ;

Browning, R ;

Kotlewski, A ;

Haywood, LJ ;

Pruitt, C ;

Warner, A ;

Machuca, K ;

Behboodikhah, M ;

Delano, S ;

Brodsky, MA ;

Ahmadi-Kashani, M ;

Rubin, AM ;

Fattoruso, L ;

O'Neill, G ;

Skadsen, A ;

Linz, P ;

Kozlowski, J ;

Feld, GK ;

Tone, LM ;

Rapoport, E ;

Somelofski, CA ;

Havranek, EP ;

Smith, I ;

Rosenfeld, LE ;

Vanzetta, AM ;

Hamilton, S ;

Kirmser, R ;

Williams, D ;

Mbonu, ID ;

Gooray, D ;

Shetty, R .

AMERICAN HEART JOURNAL, 2002, 143 (06) :991-1001

[5] ANTIARRHYTHMIC DRUG-THERAPY AND CARDIAC MORTALITY IN ATRIAL-FIBRILLATION [J].

FLAKER, GC ;

BLACKSHEAR, JL ;

MCBRIDE, R ;

KRONMAL, RA ;

HALPERIN, JL ;

HART, RG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :527-532

[6] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].

Go, AS ;

Hylek, EM ;

Phillips, KA ;

Chang, YC ;

Henault, LE ;

Selby, JV ;

Singer, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375

[7] Cost-effectiveness of rhythm versus rate control in atrial fibrillation [J].

Marshall, DA ;

Levy, AR ;

Vidaillet, H ;

Fenwick, E ;

Slee, A ;

Blackhouse, G ;

Greene, HL ;

Wyse, G ;

Nichol, G ;

O'Brien, BJ .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (09) :653-661

[8] Management of atrial fibrillation: Review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography [J].

McNamara, RL ;

Tamariz, LJ ;

Segal, JB ;

Bass, EB .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (12) :1018-1033

[9] Catheter ablation for paroxysmal atrial fibrillation - Segmental pulmonary vein ostial ablation versus left atrial ablation [J].

Oral, H ;

Scharf, C ;

Chugh, A ;

Hall, B ;

Cheung, P ;

Good, E ;

Veerareddy, S ;

Pelosi, F ;

Morady, F .

CIRCULATION, 2003, 108 (19) :2355-2360

[10] Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation - Outcomes from a controlled nonrandomized long-term study [J].

Pappone, C ;

Rosanio, S ;

Augello, G ;

Gallus, G ;

Vicedomini, G ;

Mazzone, P ;

Gulletta, S ;

Gugliotta, F ;

Pappone, A ;

Santinelli, V ;

Tortoriello, V ;

Sala, S ;

Zangrillo, A ;

Crescenzi, G ;

Benussi, S ;

Alfieri, O .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :185-197

← 1 2 →